Decoding the roles of CCL11 in human malignancies and clinical implications
- 21 August 2025
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 242 (Pt 1) , 117255
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Planning Social Development Project of Zhenjiang City (SH2024026)
- National Natural Science Foundation of China (81772641)
This publication has 96 references indexed in Scilit:
- Tryptophan 2,3‐dioxygenase‐positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine‐mediated ferroptosis resistance of metastatic cells and T cell dysfunctionCancer Communications, 2024
- Eosinophil‐Activating Semiconducting Polymer Nanoparticles for Cancer Photo‐ImmunotherapyAngewandte Chemie International Edition, 2024
- Exploring CCL11 in breast cancer: unraveling its anticancer potential and immune modulatory effects involving the Akt-S6 signalingJournal of Cancer Research and Clinical Oncology, 2024
- Identification of angiogenesis‐related subtypes, the development of a prognosis model, and features of tumor microenvironment in colon cancerBiotechnology and Applied Biochemistry, 2023
- Elevated serum eotaxin and IP‐10 levels as potential biomarkers for the detection of esophageal squamous cell carcinomaJournal of Clinical Laboratory Analysis, 2021
- Methylated of genes behaving as potential biomarkers in evaluating malignant degree of glioblastomaJournal of Cellular Physiology, 2017
- Is Eotaxin-1 a serum and urinary biomarker for prostate cancer detection and recurrence?The Prostate, 2015
- Chemokines and Skin DiseasesArchivum Immunologiae et Therapiae Experimentalis, 2014
- Helicobacter infection and gastric neoplasiaThe Journal of Pathology, 2005
- Genomic Organization, Complete Sequence, and Chromosomal Location of the Gene for Human Eotaxin (SCYA11), an Eosinophil-Specific CC ChemokineGenomics, 1997